Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


From precision diagnosis to precision treatment in epilepsy

Technological advances over the past decade have made precision genetic diagnosis available to many patients. The findings of a new study demonstrate that genetic diagnosis in epilepsy can lead to changes in clinical management that manifest as positive outcomes for the patient. The results herald a new era in which precision diagnosis will lead to precision medicine.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout


  1. Helbig, I., Heinzen, E. L. & Mefford, H. C. Primer part 1 — the building blocks of epilepsy genetics. Epilepsia 57, 861–868 (2016).

    Article  Google Scholar 

  2. McKnight, D. et al. Genetic testing to inform epilepsy treatment management from an international study of clinical practice. JAMA Neurol. (2022).

    Article  Google Scholar 

  3. Bayat, A. et al. Impact of genetic testing on therapeutic decision-making in childhood-onset epilepsies — a study in a tertiary epilepsy center. Neurotherapeutics 19, 1353–1367 (2022).

    Article  CAS  Google Scholar 

  4. Johannesen, K. M. et al. Utility of genetic testing for therapeutic decision-making in adults with epilepsy. Epilepsia 61, 1234–1239 (2020).

    Article  Google Scholar 

  5. de Lange, I. M. et al. Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes. Epilepsia 59, 1154–1165 (2018).

    Article  Google Scholar 

  6. van der Sanden, B. P. G. H. et al. The performance of genome sequencing as a first-tier test for neurodevelopmental disorders. Eur. J. Hum. Genet. (2022).

    Article  Google Scholar 

  7. Oates, S. et al. Incorporating epilepsy genetics into clinical practice: a 360° evaluation. NPJ Genom. Med. 3, 13 (2018).

    Article  Google Scholar 

  8. Hayden, E. C. Drug for rare epilepsy causes brain side effect. The New York Times (2022). Accessed October 2022

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Katrine M. Johannesen.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Johannesen, K.M. From precision diagnosis to precision treatment in epilepsy. Nat Rev Neurol 19, 69–70 (2023).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing